Latest article
Novo Nordisk to launch GLP-1 injectible diabetes drug in pill type by February
Novo Nordisk, headquartered in Denmark and a leader in the diabetes market, plans to launch this oral GLP-1 drug in India by February 2022....
Tandem Diabetes Care Inc. (TNDM) Soars 4.55% on March 30
Market overview
consequences
Tandem Diabetes Care Inc. is a medical device company that develops products for people with insulin-dependent diabetes. The company has...